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Aortic aneurysms are common and life threatening problems with high rates of death. The initiation and progression of aneu-
rysms are characterized by extensive extracellular matrix degradation and immune cells invasion within arterial wall. During 
the pathogenesis of all aneurysms, inflammation and immune cells play a significant role. Although T cells are abundant in 
aneurysm tissue, their functions in initiation and propagation of aneurysms remain unclear. This review summarizes the current 
state of knowledge of T lymphocytes on this disease and focuses on potential mechanisms of specific T cell responses. 
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Aortic aneurysms, the common life-threatening problem, 
have been recognized as major causes of death for centuries 
[1,2]. Because of the silence without symptoms and predis-
position for rupture, aortic aneurysms always go undetected 
until fatal rupture which contributes to 80%90% mortality 
[1,3]. Aneurysms can develop in any artery and therefore be 
classified by anatomic location, such as coronary artery 
aneurysms [4,5], intracranial artery aneurysms (IAs) [68]. 
There are two predominant distributions of aortic aneu-
rysms in patients. One is abdominal aortic aneurysm (AAA), 
the most common form that is typically associated with but 
independent of atherosclerosis [9]. The second common 
type is thoracic aortic aneurysms (TAA) which is highly 
associated with hereditary influences and show less associa-
tion with atherosclerosis [1,10,11]. All of these aneurysms 
share many similar features in common, while having dif-
ferent physical structures which contribute to the different 
pathologies in origin and evolution [11]. 
Recently, accumulated reports suggest that aneurysms 
may not arise entirely through atherosclerosis and, at least, 
many other etiologic factors are also involved in the disease 
development. Atherosclerosis may not directly cause AAA, 
but can trigger the first inflammation to induce the infil-
trates. The underlying causes could be atherosclerosis, to-
bacco smoking, familial clustering, genetic background and 
environmental factors [9,12]. 
The main organization of aortic wall includes elastin and 
collagen: elastic fibres and smooth muscle cells in the me-
dia are required for mechanical properties of the aorta; col-
lagen (especially types I and III) in adventitia maintains 
structural integrity. Elastin fragmentation and medial atten-
uation are the most histological features of aneurysm de-
velopment, while adventitial collagen degradation ultimate-
ly favors the rupture. Besides, VSMCs apoptosis also has an 
effect on vessel wall weakening [11]. The alterations and 
remodeling of these connective tissues resulted from prote-
ases production. Medial smooth muscle cells (SMCs), ad-
ventitial fibroblasts and inflammatory cells are the main 
sources of these matrix-degrading proteases [2,9,13]. The 
infiltration cells in all layers of the wall, most important 
pathologic features of aneurysms, include monocytes, lym-
796 Lv BJ, et al.   Sci China Life Sci   August (2014) Vol.57 No.8 
phocytes and plasma cells. In addition to release proteases, 
these cells secrete overwhelming inflammatory cytokines 
and participate in the destruction of the aortic wall and pro-
gression of enlargement and rupture [9,14,15]. Lympho-
cytes, apart from macrophages, are the predominant in-
flammatory cells found in aneurysm tissue [15,16]. There-
fore, understanding the pathogenesis of T cells in aneu-
rysms has become increasingly prior and will provide im-
portant insights into basic research and clinical practice. So 
far, some potential pathogenic mechanisms of formation 
and development of this disease have been found. Here we 
focus on the current mechanisms of T cells in the develop-
ment of aortic aneurysms. 
1  T cells in aneurysms 
Not only elastin fragments, but also the production of proin-
flammatory cytokines, chemokines by immune cells them-
selves promote the T cells recruitment into the wall [9]. 
Immunohistochemical staining and flow cytometry sug-
gested that elevated numbers of CD3+ cells (include both 
CD3+ TCRαβ+ and CD3+ TCRγδ+ cells), localizing in aortic 
media and adventitia, were present in aneurysm patients 
[16,17], which may further led to the death of VSMCs [18]. 
With the evidence that oligoclonal αβ TCR+T cell popula-
tions expansion in aneurysmal lesions from AAA patients, 
AAA is considered as a specific antigen-driven T cell dis-
ease [19,20]. The T cell co-stimulatory factors CD28 and 
CTLA-4, as well as their ligands CD80 and CD86 have 
been found in AAA patients, with sCD28 and sCD86 in-
creased and sCTLA-4 decreased in plasma. Although they 
failed to predict the size of aneurysm, sCTLA-4 and sCD80 
levels were correlated negatively with matrix metallopro-
tienase-9 (MMP-9) [21]. 
Although T-cell immunodeficiency has been reported to 
develop progressive intracranial aneurysms in 15-year-old 
patients [22], lymphocyte deficiency may not affect AAA 
formation in Rag-1 mice [23]. The fact that Rag-1 defi-
ciency influences not only T cells but also non-lymphocytic 
leukocyte populations may be responsible for it. Further-
more, it should be noted that different T cell subsets have 
complex effects during inflammatory response and may 
even counteract each other. 
2  CD4+ T cell subsets in artery aneurysms 
The inflammatory infiltrate in the aortic wall in aneurysms 
is dominated by CD4+ T cells with activated memory phe-
notype. Naïve CD4+T cells have been divided into several 
subsets by the ability to produce specific cytokines. Th1 and 
Th2 subsets are characterized by production of IFN-γ and 
IL-4 respectively, which may drive opposing effects on 
immune process. Natural regulatory T (nTreg) cells and in-
duced Treg (iTreg) cells can produce TGF-β, IL-10 and IL-35. 
Th17 cells produce IL-17A and IL-17F as their signature 
cytokines. Studies described below show evidence of these 
subsets in aneurysms of both mice and human. We also 
highlight the possible mechanisms. 
3  Th1 cells  
Several reports consider Th1 as predominant type of CD4+T 
in AAA [17,2430]. Galle [26] and Tang et al. [31] identi-
fied CD4+ T cells production of high levels of IFN-γ but not 
IL-4 in human aneurysmal aortic lesion from both gene and 
protein levels. Overexpression of the transcription factor 
T-bet and the absence of GATA-3 expression further proved 
the Th1 cells participating in human AAA lesions. Fur-
thermore, in terms of function, Xiong et al. [24] confirmed 
the contributions of Th1 cells and IFN-γ in the development 
of AAA. AAA formation was suppressed in CD4-deficient 
(CD4) mice or IFN-γ-deficient (IFN-γ) mice, whereas 
IFN-γ could partially reconstitute aneurysms with restored 
levels of matrix metalloproteinase-2 (MMP-2) and -9 
(MMP-9) secreting by SMCs and macrophages, respective-
ly [24]. Chan et al. [25] suggested that IFN-γ could increase 
Fas expression in VSMCs, thereby inducing VSMC apopto-
sis. In addition, the observations that IFN-γ can cause type I 
and III collagen reduction [32,33] may also account for its 
role in progression of aneurysms. In particular, Th1 cells 
positively correlate with increased aortic external diameter 
and expansion in aneurysm patients [31]. In line with these 
findings, the elevated levels of IFN-γ may predict aneurysm 
expansion in patients [28].  
Although confirming IFN-γ-producing Th1 cells as the 
master regulators, results from some research, by contrast, 
suggest the protection role of Th1 cells in aneurysms. 
Shimizu et al. [34] found that IFN-γ receptor-deficient 
(GRKO) mice had an increased incidence of aneurysm for-
mation and spontaneous rupture, thereby implying the pro-
tective role of IFN-γ in aneurysms. Similar to these findings, 
King et al. [35] confirmed the protective role of IFN-γ in 
aneurysms. They suggested that IFN-γ deficiency (IFN-γ) 
led to increased incidence of AAAs in Ang II treated 
apolipoprotein E deficient (ApoE) mice. The deletion   
of CXCL 10, an IFN-γ-inducible effector T-cell chemokine, 
resulted in high rates of death to aortic rupture in      
Ang II-infused AAA mice. Taken together, IFN-γ may  
protect against elastin degradation and inhibit aneurysm 
formation [34]. 
However, other cell types such as NK cells, NKT cells, 
macrophages and SMCs can also release high amounts of 
IFN-γ, which may have complex impact on the aneurysm 
formation [25,26]. Thus, the results may be multiplied by 
the following factors. Firstly, the difference in the temporal 
accumulation of different cell types could interfere with the 
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evaluation of IFN-γ production by Th1 cells, which may 
shake the Th1 predominance. Besides, the signaling path-
way by direct cell contact may be different from indirect 
action of cytokines. For instance, the protection role of Th1 
cells interaction with the resident vascular wall cells may be 
counterbalanced by IFN-γ, the proinflammatory cytokine 
that promotes the death of VSMCs. Most importantly, 
IFN-γ may enhance the proliferation and function of other 
immune cells which exert opposite effects on AAA patho-
genesis, therefore, counteracting the effects of IFN-γ. 
4  Th2 cells 
Other groups have found evidence that the AAA infiltrates 
are predominantly IL-4-produicng Type 2 lymphoid cells 
[21,34,3640], which contrasts with previous studies sug-
gesting the predominance of Th1 disorder. Schonbeck et al. 
[36], the first group supporting the dominant expression of 
Th2 response in AAA, found that there were difference be-
tween AAA and stenosis atheroma in the CD4+ T cell pre-
dominance. AAA tissues showed elevated levels of Th2 
associated cytokines IL-4, IL-5 and IL-10, but little or no 
expression of Th1 producing cytokines. In contrast, extracts 
of human atherosclerotic plaques expressed high levels of 
characteristic Th1 cytokines rather than Th2 cytokines. Not 
only having been proved in mice model, Th2-predominant 
inflammation has also been found in patients with coronary 
artery ectasia (CAE). The decreased levels of serum TNF-α 
and IL-18, strong Th1 stimulating cytokines, indicated the 
lack of Th1 cells response and the predominance of Th2 in 
CAE patients [38]. 
By expressing high levels of Fas-associated phosphatase 
(FAP-1), Th2 subset inhibits Fas signaling and causes death 
of Th1 cells, and even SMCs in AAA. Additionally, IL-4 
induces the expression of MMP-1 and MMP3 in mononu-
clear phagocytes and SMCs, which enhances the colla-
genolytic and elastolytic activities. All of these demonstrate 
a Th2 immune pattern of matrix-degrading enzymes in 
AAA different from Th1 predominant immune response in 
atherosclerosis [36]. Shimuzu et al. [34] extended this theo-
ry in an allografted aortas model. Aortic allografts in IFN-γ 
receptor-deficient (GRKO) recipients resulted in the devel-
opment of aortic aneurysms, which suggested IL-4 pre-
dominance response. This IL-4-driven inflammation model 
showed high levels of MM-9 and MMP-12. On the other 
hand, GRKO recipients with IL-4 blockade resulted in pre-
vention of aortic aneurysm formation and showed minimum 
of elastic degradation. They further found that IL-4 im-
proved and IFN-γ diminished MMP-9 and -12 expression in 
macrophages, suggesting a new finding that Th2 and IL-4 
can act as important stimulus to AAA formation. 
Although IL-4 attracts more particular interest among 
prototypical Th2 cytokines, recent research shows that the 
elevation of IL-5, another Th2 cytokine, is present in the 
early phase of Ang-II induced AAA formation. The inhibi-
tion of IL-5 could prevent AAA development, which is as-
sociated with the failure in up-regulation of MMP-2 and 
MMP-9. Potential mechanisms that are involved include the 
regulation of IL-5 in both innate and acquired immunity, 
and the direct roles of IL-5 on SMCs [39]. 
Some reports demonstrated that IL-13, in pulmonary 
diseases, acted as potent stimulator of MMPs (especially 
MMP-2, -9, -12, -13 and -14) and cathepsins (such as ca-
thepsin B, S, L, H, and K) [41,42]. However, the lack of 
evidence that IL-13 leads to MMPs up-regulation in aneu-
rysms forces us to identify its contribution to aneurysm 
formation and development. 
However, two points are worth highlighting here about 
Th2 cells in aneurysms. Firstly, since Th2 cytokines are 
usually considered as strong anti-inflammatory mediators, 
why can they drive proinflammatory activities in aneurysms? 
Secondly, why are there apparent contradictions on the 
predominance of CD4+ T cell subsets? 
Th2 cytokines can lead to a proinflammatory response in 
some models such as allergic asthma. Therefore, there is 
reason to believe that traditional anti-inflammation cyto-
kines may have proinflammatory effects in aneurysms: IL-4 
increases elastolytic activities; IL-5 up-regulates MMP-2 
and -9 levels; IL-13 induces MMP-2, -9, -12, -13, and -14 
expression. 
Which type of CD4+ T cells predominantly mediates in 
aneurysm degeneration has not been concluded yet, and 
these discordant findings may result from several aspects. 
Since AAA formation does not necessarily require preex-
isting atherosclerosis and there are considerable differences 
between them [43], the mechanisms initiating and stimulat-
ing progression of aneurysms remain poorly understood. 
Therefore, it is possible that the shared environmental (such 
as smoking, hypertension and obesity) and genetic risk fac-
tors (such as family history, a locus on chromosome 9p21 or 
19q13) may interfuse and perplex the mechanism of aneu-
rysms [44]. In addition, there are several types of aneurysms 
and the pathogenesis of them is different [3]. The stage and 
size of aneurysm may also contribute to the degree of elas-
tin and collagen degradation [12], followed by different 
CD4+ T cells infiltration including a Th1/Th2 balance or a 
shift to Th1/Th2. 
It is not odd that Th1 or Th2 participates in the early 
phase of some types of aneurysm and the other appears in 
the later phase. But we wonder what exactly these cells are 
during the distinct phases and how these cells response in 
the aneurysm formation. The most likely mechanisms that 
integrate the current data regarding Th1 and Th2 response 
are as follows. In atherosclerosis based aneurysms, Th1 
cells potentiate atherosclerosis and macrophages are also 
needed for the initial inflammatory cell recruitment. How-
ever, this Th1-dominated obstructive pathway is not enough 
to develop aneurysms, which require further stimulus. The 
potential secondary triggers that initiate the aneurysm stage 
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are the risk factors of aging and smoking. Both of the fac-
tors induce large amounts of IL-4 yet suppress IFN-γ pro-
duction, which elicits Th2 dominance milieu and inhibit the 
Th1 cytokine signaling. Moreover, by secreting cytokines, 
Th2 cells could further restrict Th1 cells reaction but favor 
themselves. Thus, the Th1 predominant response shifts to 
Th2 predominance and aneurysms will develop. Therefore, 
the depletion of IFN-γ or other Th1 cytokines leads to the 
reduction of initial inflammation, followed by diminished 
proteases activity and protection of aneurysms. Targeting 
cigarettes and ages and blocking Th2 related cytokines will 
prevent aneurysms from dilation and rupture [12,15,45]. 
Of note, all the theories should take into account that NK 
and NKT cells can also produce Th1 and Th2 cytokines 
(IFN-γ and IL-4). In order to elucidate the nature and 
unique role of T lymphocytes, future research should use 
both T and NK markers to characterize cell subsets infiltra-
tion in aneurysms [37]. 
5  Th17 cells  
There is a significant increase of IL-17 and IL-23 expres-
sion in human aortic tissue of AAA patients. Besides, CD4+ 
T cells from aortic walls of WT mice showed high produc-
tion of IL-17. The contribution of IL-17 in aneurysm de-
velopment may be related to its role in modulating SMCs 
activation. Therefore, the depletion of IL-17 showed attenu-
ated aortic diameter and cytokine production [46]. This the-
ory was confirmed by Ju et al. [47], who found that 
IL-6-signal transducer and activator of transcription-3 
(IL-6-STAT3) signaling pathway contributed to Th17 re-
cruitment, promoting aneurysm formation. 
On the contrary, the protection role of IL-17 is docu-
mented by other groups [4850]. Depletion of STAT3 in T 
cells, as a result of overexpression of suppressor of cytokine 
signaling 3 (SOCS3-Tg mice), led to decreased IL-17 pro-
duction. Thus, repopulation of C57BL/6 mice with 
SOCS3-Tg bone marrow, or adoptive transfer of SOCS3-Tg 
CD4+ T cells in Rag mice markedly increased the severity 
and mortality of AAA, with elevated accumulation of mac-
rophages in the wall. The deficiency of STAT3 signaling in 
T cells, rather than in macrophages or in neutrophils, con-
tributed to AAA formation [48]. In vivo suppression of 
STAT3 signaling or blockade of IL-17A aggravated AAA 
in mice as shown by increased aneurysm incidence, as well 
as severity and mortality from fatal rupture [49]. Further-
more, Xiong et al. [50] found that expression of IL-23 and 
IL-17 decreased in mice aneurysm tissues. The absence of 
IL-23 resulted in enlarged aneurysms with high levels of 
MMP-2 and -9, which suggested a protective role for 
IL-23-IL-17 axis in AAA development. All these findings 
indicate that Th17 cells play a protective role in the devel-
opment of AAA. 
Madhur’s research [51], however, suggested that IL-17A 
did not influence aneurysm development. Despite that 
IL-17A promotes the aortic inflammatory cell recruitment, 
this cytokine showed no effect on aneurysm formation and 
extracellular matrix degradation. 
6  Regulatory T cells (Tregs) 
CD4+CD25+ regulatory T cells (Tregs), with the key ex-
pression of transcription factor Foxp3, are a subpopulation 
of CD4+ T cells dispensable for immune self-tolerance and 
homeostasis. The majority of natural Treg cells (nTregs) 
derive from thymus, while others differentiate from periph-
eral naïve conventional T cells (Tconv), known as induced 
Treg cells (iTegs) [52]. One mode of action of Tregs in 
suppression of various effector lymphocytes is by inhibitory 
cytokines, mainly including IL-10, TGF-β and IL-35 [53]. It 
seemed that Tregs and its cytokines play a protective role in 
aneurysms. However, it is not always the case. 
It is documented that reduced number and function of 
CD4+CD25+FOXP3+ Tregs in aneurysm patients contribute 
to aneurysm pathogenesis and may predict resistance to 
therapy in some cases [54–56]. Inhibition of Tregs in 
CD25-specific antibody blockade or CD80//CD86/ mice 
model showed promotion of AAA development and rupture. 
Furthermore, marked limitation of aneurysm development 
was seen in CD28mice with Tregs supplement. The defi-
ciency of Treg cells was associated with a blunted IL-10 
and IL-10 mice showed increased susceptibility to AAA, 
suggesting an IL-10 dependent way for the protective role 
of Tregs [57]. Exogenous IL-10 into AAA explants from 
patients could reduce the production of IL-6, and more im-
portantly, played a protective role in modulating AAA im-
mune networks [58]. 
The activity of TGF-β, another cytokine of Tregs, was 
identified to prevent aneurysm progression [5961]. Sys-
temic inhibition of TGF-β failed to protect mice from AAA 
formation and rupture, associated with increased accumula-
tion of macrophages and T lymphocytes, great loss of SMCs 
and enhanced degradation of elastin. The up-regulation of 
MMP-12 activity in anti-TGF-β treated mice also contrib-
uted to aneurysm formation [59]. Overexpression of TGF-β 
in hearts of ApoE transgene mice showed less T cell infil-
tration, more collagen, reduced inflammatory cytokines and 
MMP-13, as well as increased metalloproteinase-2, with 
suppression of aneurysm formation [60]. However, TGF-β 
may have multi-functional effect on aneurysms. Kawasaki 
disease (KD) is characterized by inflammation, as well as 
coronary aneurysms. Coronary artery tissues from KD pa-
tients were used to determine the role of TGF-β in aneu-
rysms. Despite that TGF-β facilitates the differentiation of 
Tregs from naïve T cells, TGF-β also promotes the genera-
tion of myofibroblasts from endothelial cells. The elevated 
production of myofibroblasts leads to enhanced recruitment  
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of inflammation cells and damage to aortic walls, followed 
by aggravation of aneurysms. Therefore, TGF-β may con-
tribute to the pathogenesis of KD, but cease the inflamma-
tion by eliciting Tregs [62]. 
IL-35, an emerging cytokines, is produced mainly by 
nTregs in CD4+ T cells [61]. Although the role of this cyto-
kine in aneurysms is not clear, a recent report [63] showing 
that IL-35 infiltration in human atheroma plaques may merit 
further investigation into its contribution to aneurysms. 
7  CD8+ T cells 
Accumulation of reports document that CD8+ T cells infil-
trate aneurysm lesion both from human and mice tissues 
[13,14,17,26,31,46,54,64–71]. The predominant cell types 
within the infiltrate in AAA tissues are CD3+ T cells (more 
than 50%), including CD4+ T cells and CD8+ T cells [17]. 
CD8+ T cells have been found, dating as far back as 1999, 
in AAAs rather than normal aorta. These CD8+ T cells ex-
pressed well-characterized cytotoxic mediators, perforin and 
Fas, the death-promoting proteins. Perforin contributes to 
membrane damage and Fas acts by ligand-receptor interac-
tion, which leads to the death of SMCs and elimination of 
elastin and collagen [70]. Consistent with this report, Duf-
ner et al. [69] suggested that both peripheral and tissue  
percentages of CD8+ T cells were enriched in AAA patients 
compared with healthy controls with increased production 
of IFN-γ and perforin. Similarly, further research showed 
that IFN-γ-producing CD8+ T cells, but not CD4+ T    
cells, contributed to aneurysm formation as shown by   
enhanced SMCs death and MMP-producing macrophage 
recruitment [68].  
Brown et al. [64] suggested that CD8+ T cells predomi-
nated over CD4+ T cells in coronary artery aneurysms of 
acute Kawasaki disease (KD). This finding indicated that 
CD8+ T cells’ cytotoxic activity may be harmful to the 
pathogenesis of coronary aneurysm, with the potential 
mechanism of prolonging inflammation in arterial wall 
thereby promoting aneurysm formation [66]. 
It should be noted that there are subsets of CD8+ T cells, 
and the roles of specific subpopulations in human and mice 
AAA, however, remains to be identified. Since circulating 
CD4+/CD31+ T cells have been reported to favor CD8+ T 
cells proliferation and cytokine production in the aneurys-
mal arterial wall [54], the relationship between CD4+ T cells 
and CD8+ T cells in aneurysms needs to be confirmed. 
8  γδ TCR+ T cells 
Besides αβ T cells infiltration in aneurysms, γδ T cells are 
also present and play an important role in aneurysms [19]. 
Most of the infiltrating T cells in Takayasu’s arteritis (TA), 
a chronic inflammation response with hallmark of stenosis 
or aneurysm of large elastic arteries, consist of gamma delta 
(γδ) T cells. These cells in TA produced large amounts of 
IFN-γ rather than IL-4 and IL-10 [72]. But the lack of evi-
dence about γδ T cells interaction with SMCs and other 
immune cells in classical aneurysms, such as AAA, propels 
us to identify their roles in atherosclerosis and other types of 
aneurysm. 
9  Conclusion 
T cells critically regulate aortic aneurysms by augmenting 
the chronic inflammation. While some T cell subsets ag-
gravate aneurysms, other subsets or in some contexts they 
can limit inflammation and counteract protease activity. 
Experimental animal models have great help in confirming 
the role of these T cells in aneurysms, although many of 
them do not fully simulate human disease. Models that are 
close to human state should be developed to clarify which 
subsets are detrimental and which are potentially beneficial. 
Although our understanding of aortic aneurysms and their 
treatment has progressed, much remains unknown. There-
fore, further mechanisms of T-cell-mediated regulation and 
cross-talk between activated T cell subsets and other im-
mune cells are needed for effective treatment to prevent 
aneurysms expansion and rupture. 
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